Mika Scheinin
 MD, PhD, Professor Emeritus

Publications

  

  

  

23 of 25

  

  

  

---

• Dexmedetomidine decreases serum insulin concentrations and this response is influenced by alpha2a adrenoceptor genetic variation  (2012)  
  • Clinical Pharmacology and Therapeutics
   Ghimire LV, Kurnik D, Muszkat M, Sofowora GG, Scheinin M, Wood AJ, Stein C
  (Other publication)

  
  

• Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease  (2012)  
  • Archives of Neurology -Chigago-
   Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E, AAB-001 201/202 Investigators (incl. Scheinin M)
  (A1 Refereed original research article in a scientific journal)

  
  

• G-proteiinikytkentäiset reseptorit merenkulun palveluksessa: stressilääkkeen uusi käyttöaihe  (2012)  
  • Sphinx
   Scheinin Mika
  (B1 Non-refereed article in a scientific journal)

  
  

• High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors.  (2012)  
  • European Journal of Pharmaceutical Sciences
   Fallarero Adyary, Pohjanoksa Katariina, Wissel Gloria, Parkkisenniemi-Kinnunen Ulla-Mari, Xhaard Henri, Scheinin Mika, Vuorela Pia
  (A1 Refereed original research article in a scientific journal)

  
  

• Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.  (2012)  
  • Drug Metabolism and Disposition
   Honkavaara Juhani, Restitutti Flavia, Raekallio Marja, Salla Kati, Kuusela Erja, Ranta-Panula Ville, Rinne Valtteri, Vainio Outi, Scheinin Mika
  (A1 Refereed original research article in a scientific journal)

  
  

• Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia.  (2012)  
  • Neuroendocrinology
   Ruohonen ST, Ruohonen S, Gilsbach R, Savontaus E, Scheinin M, Hein L
  (A1 Refereed original research article in a scientific journal)

  
  

• Lääkeaineiden vaikutusmekanismit: reseptorit  (2012)  Farmakologia ja toksikologia Scheinin Mika
  (A3 Refereed book chapter or chapter in a compilation book)

  
  

• Might the observed α2A-adrenoceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?  (2012)  
  • Bioorganic and Medicinal Chemistry
   Diamanti Eleonora, Del Bello Fabio, Carbonara Giuseppe, Carrieri Antonio, Fracchiolla Giuseppe, Giannella Mario, Mammoli Valerio, Piergentili Alessandro, Pohjanoksa Katariina, Quaglia Wilma, Scheinin Mika, Pigini Maria
  (A1 Refereed original research article in a scientific journal)

  
  

• Pharmacokinetics of [F-18]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease  (2012)  
  • European Journal of Nuclear Medicine and Molecular Imaging
   Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M
  (A1 Refereed original research article in a scientific journal)

  
  

• Synthesis and biological activities of 2- [(heteroaryl)methyl]imidazolines  (2012)  
  • Bioorganic and Medicinal Chemistry
   Saczewski Jaroslaw, Hudson Alan, Scheinin Mika, Rybcynska Apolonia, Ma Daqing, Saczewski Franciszek, Laird Shayna, Laurila Jonne M, Boblewski Konrad, Lehmann Artur, Gu Jianteng, Watts Helena
  (A1 Refereed original research article in a scientific journal)